Intriguingly the authors also present data suggesting that this pathway is dysfunctional in platelets from patients with Parkinson's disease (PD) and demonstrate selective reduction in MsrB2 and LCII, and increased apoptosis in PD platelets. This evidence concerns the gene MSRB2 and Parkinson disease.